{"id":"https://openalex.org/W39133231","doi":null,"title":"Stribild\u00ae (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatment.","display_name":"Stribild\u00ae (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatment.","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W39133231","mag":"39133231","pmid":"https://pubmed.ncbi.nlm.nih.gov/24584107"},"language":"en","primary_location":{"id":"mag:39133231","doi":null,"is_oa":false,"landing_page_url":"http://aidsreviews.com/files/2014_16_1_035-042.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S115796062","display_name":"Aids Reviews","issn_l":"1139-6121","issn":["1139-6121","1698-6997"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Aids Reviews","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W39133231"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049487728","display_name":"Christian Manzardo","orcid":"https://orcid.org/0000-0001-8893-6177","observed_orcids":["https://orcid.org/0000-0001-8893-6177"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Christian Manzardo","raw_affiliation_strings":["Infectious Diseases and AIDS Unit, Hospital Clinic/IDIBAPS, University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases and AIDS Unit, Hospital Clinic/IDIBAPS, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I71999127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107890842","display_name":"Jos\u00e9 M. Gatell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 M Gatell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.8769,"has_fulltext":true,"cited_by_count":19,"citation_normalized_percentile":{"value":0.90509011,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"16","issue":"1","first_page":"35","last_page":"42"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/elvitegravir","display_name":"elvitegravir","score":0.953000009059906},{"id":"https://openalex.org/keywords/cobicistat","display_name":"cobicistat","score":1.0},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/atripla","display_name":"Atripla","score":0.7979999780654907},{"id":"https://openalex.org/keywords/ritonavir-boosted-atazanavir","display_name":"ritonavir-boosted atazanavir","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cd4-t-cell-reconstitution","display_name":"CD4+ T cell recovery","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8700000047683716},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.8949999809265137},{"id":"https://openalex.org/keywords/reduced-glomerular-filtration-rate","display_name":"reduced glomerular filtration rate","score":0.7940000295639038},{"id":"https://openalex.org/keywords/renal-tubular-transporters","display_name":"renal tubular transporters","score":0.5320000052452087},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2780524789","wikidata":"https://www.wikidata.org/wiki/Q5138908","display_name":"Cobicistat","level":5,"score":0.9809494018554688},{"id":"https://openalex.org/C2777068322","wikidata":"https://www.wikidata.org/wiki/Q2740966","display_name":"Elvitegravir","level":5,"score":0.9649675488471985},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.8251965045928955},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.7739228010177612},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7010794878005981},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.6969273090362549},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.6295034885406494},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5345100164413452},{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.4520799517631531},{"id":"https://openalex.org/C2776769776","wikidata":"https://www.wikidata.org/wiki/Q900898","display_name":"Probenecid","level":2,"score":0.450943261384964},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.4470679759979248},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.31737732887268066},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2436918318271637},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.13467642664909363},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.10409390926361084}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069547","descriptor_name":"Cobicistat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"mag:39133231","doi":null,"is_oa":false,"landing_page_url":"http://aidsreviews.com/files/2014_16_1_035-042.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S115796062","display_name":"Aids Reviews","issn_l":"1139-6121","issn":["1139-6121","1698-6997"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Aids Reviews","raw_type":null},{"id":"pmid:24584107","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24584107","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2735395142","display_name":"\u5927\u578b\u98df\u7528\u771f\u83cc\u6ed1\u83c7\u6b21\u7ea7\u4ee3\u8c22\u4ea7\u7269\u6316\u6398\u53ca\u751f\u7269\u6d3b\u6027\u7814\u7a76","funder_award_id":"32060104","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W127131570","https://openalex.org/W1982419299","https://openalex.org/W1993363443","https://openalex.org/W1996021566","https://openalex.org/W1999771338","https://openalex.org/W2007831756","https://openalex.org/W2014673451","https://openalex.org/W2017404902","https://openalex.org/W2026757281","https://openalex.org/W2030301242","https://openalex.org/W2045730529","https://openalex.org/W2046399600","https://openalex.org/W2048598834","https://openalex.org/W2061741734","https://openalex.org/W2061817517","https://openalex.org/W2063933031","https://openalex.org/W2072527802","https://openalex.org/W2075531822","https://openalex.org/W2088739874","https://openalex.org/W2104161734","https://openalex.org/W2110944532","https://openalex.org/W2134537454","https://openalex.org/W2143930204","https://openalex.org/W2145467751","https://openalex.org/W2148750104","https://openalex.org/W2151050670","https://openalex.org/W2153000646","https://openalex.org/W2156933277","https://openalex.org/W2322864883"],"related_works":["https://openalex.org/W2115437760","https://openalex.org/W2073411977","https://openalex.org/W1982419299","https://openalex.org/W2314973210","https://openalex.org/W1974686877","https://openalex.org/W2316242388","https://openalex.org/W1968543449","https://openalex.org/W4255502502","https://openalex.org/W2409300820","https://openalex.org/W2042812358"],"abstract_inverted_index":{"Stribild\u00ae":[0,49],"(elvitegravir/cobicistat/emtricitabine/tenofovir":[1],"disoproxil":[2],"fumarate)":[3],"is":[4,28],"a":[5,40,56,134],"new":[6],"single-tablet,":[7],"fixed-dose":[8],"formulation":[9],"approved":[10],"by":[11,125],"both":[12,112],"the":[13,20,29,126,139],"US":[14],"Food":[15],"and":[16,19,38,55,67,84,94,132],"Drug":[17],"Administration":[18],"European":[21],"Medicine":[22],"Agency":[23],"as":[24],"antiretroviral":[25],"therapy.":[26],"It":[27],"first":[30],"once-a-day":[31],"therapy":[32],"option":[33],"containing":[34],"an":[35],"integrase":[36],"inhibitor":[37],"cobicistat,":[39],"novel":[41],"pharmacokinetic":[42],"boosting":[43],"agent":[44],"without":[45],"activity":[46],"on":[47],"HIV.":[48],"has":[50,102,115],"demonstrated":[51],"non-inferior":[52],"virological":[53],"efficacy":[54],"similar":[57],"recovery":[58],"of":[59,109,138,147,150],"CD4+":[60,93],"T-cells":[61],"when":[62],"compared":[63],"to":[64,68,145,165,167],"Atripla\u00ae":[65],"(efavirenz/emtricitabine/tenofovir)":[66],"ritonavir-boosted":[69],"atazanavir":[70],"plus":[71],"emtricitabine/tenofovir":[72],"in":[73,91,105,111,152],"two":[74],"large,":[75],"phase":[76],"III":[77],"randomized":[78],"clinical":[79],"trials":[80],"at":[81],"48,":[82],"96,":[83],"144":[85],"weeks.":[86],"These":[87],"results":[88],"are":[89,123],"consistent":[90],"all":[92],"HIV":[95],"RNA":[96],"strata.":[97],"Although":[98],"well-tolerated,":[99],"self-limiting":[100],"nausea":[101],"been":[103],"reported":[104],"more":[106],"than":[107],"10%":[108],"patients":[110],"trials.":[113],"Cobicistat":[114],"clinically":[116],"significant":[117],"drug-drug":[118],"interactions":[119],"with":[120,160],"drugs":[121],"that":[122],"metabolized":[124],"cytochrome":[127],"P450":[128],"3A4":[129],"subfamily":[130],"enzymes,":[131],"causes":[133],"minimal":[135],"reversible":[136],"decrease":[137],"estimated":[140],"glomerular":[141],"filtration":[142],"rate":[143],"due":[144],"inhibition":[146],"molecular":[148],"transporters":[149],"creatinine":[151],"kidney":[153],"tubules.":[154],"Elvitegravir":[155],"primary":[156],"resistance":[157],"mutations":[158],"associated":[159],"treatment":[161],"failure":[162],"often":[163],"lead":[164],"cross-resistance":[166],"raltegravir.":[168]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W39133231","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
